4 year old barred from attending school for not vaccinating v chicken pox.

A story that should serve as a wakeup call to all American parents is currently making headline news: A Staten Island kindergartner has been barred from attending school because she hasn’t been vaccinated against chickenpox—even though her pediatrician refuses to vaccinate her on grounds that it may endanger the health of her baby sister.
Chickenpox is caused by the varicella zoster virus, which is a member of the herpes virus family and is associated with herpes zoster (shingles).
While highly contagious, it typically produces a mild disease characterized by small round lesions on your skin that cause intense itching that lasts for two to three weeks. Recovery leaves a child with long-lasting immunity.
The case of Frankie Wagner is a disturbing reminder of how far the US government is going in its illogical pursuit of maximizing vaccine adherence.
US public health officials say your child should receive 69 doses of 16 different vaccines before age 18. And, believe it or not, Big Pharma has 145 more vaccines in the pipeline.1

Many homeowners pay property taxes that are directly allocated for the public schools, but it is clear our government is clearly willing to take this money even though your children may not utilize these services if they don’t keep up with the medical procedures dictated – 69 doses of vaccines before they graduate!

Pediatrician’s Advice Ignored by Department of Education

According to Frankie’s mother, Elizabeth, the girl’s pediatrician does not administer live virus vaccines, like varicella zoster vaccine, to children in families with infants as they could contract vaccine strain infections. The Wagner’s other daughter is only 14-weeks old and her mother has good reason to suspect her baby daughter could have inherited an immunodeficiency disease . Elizabeth told NBC News:2
“I don’t care if it’s a one in 3 million chance. I am not willing to take the chance with my baby.”


PLUS – 

FDA approves drugs even it knows the work done is fraudulent.

FDA Approved New Drug Despite Ongoing Investigation of Lab Misconduct

by Charles Seife and Rob Garver, Special to ProPublica, April 22, 2013, 9:22 a.m.
.

(The Food and Drug Administration)
Last week, ProPublica reported that the Food and Drug Administration allowed dozens of medications to stay on the market, even though the research designed to prove their safety and effectiveness was undermined by “egregious” violations at a major pharmaceutical research laboratory in Houston. New information shows that even after the FDA had cited the lab for falsifying data and other misconduct, the agency issued a brand new approval to a drug tested there.
The FDA has refused to reveal the names of any of the approximately 100 drugs affected by the fraud at the Houston lab of the firm Cetero Research, saying that to do so would reveal confidential commercial information. ProPublica was able to identify five of those drugs, and now we’ve found a sixth. This one was approved after the agency had already cited the Houston lab for misconduct.
The drug is a generic version of Tussionex, which combines a long-acting narcotic cough suppressant with an anti-allergy medication. Manufactured by TrisPharma, the drug has a tongue-twisting chemical name: hydrocodone polistirex/chlorpheniraminepolistirex.
ProPublica discovered that both of the clinical trials used to show that the generic is equivalent to the name brand — a key requirement for FDA approval — were analyzed in May and June 2009 at the Houston lab of the firm Cetero Research. The company, which conducted research for scores of pharmaceutical companies, has acknowledged that chemists at its Houston lab committed research fraud, though it says the misconduct was limited to a handful of employees and that none of their tests have so far proven to be wrong or inaccurate.
Cetero filed for Chapter 11 bankruptcy last year and emerged with a new name, PRACS Institute. PRACS, in turn, filed for bankruptcy earlier this year.
The FDA got wind of problems at Cetero Houston in June 2009 when, prompted by a whistleblower, the company alerted the agency of potential wrongdoing.
On May 3, 2010, three FDA agents came to inspect the lab. The facility’s president turned over eight flatbed carts double-stacked with file boxes and admitted that much of the lab’s work was fraudulent, saying, “You got us,” lead agent Patrick Stone recalled. (The lab’s president declined to comment.)
On May 7, the FDA issued an inspection report that cited data falsification and other laboratory violations at the facility during the time its chemists conducted the tests for the TrisPharma drug.
But five months later, in October 2010, the FDA approved Tris’ drug for sale in the United States.

http://www.propublica.org/article/fda-approved-new-drug-despite-ongoing-investigation-of-lab-misconduct

The Tap Blog is a collective of like-minded researchers and writers who’ve joined forces to distribute information and voice opinions avoided by the world’s media.
Facebooktwitterredditpinterestlinkedinmail

One Response to “4 year old barred from attending school for not vaccinating v chicken pox.”

Leave a Reply

You must be logged in to post a comment.